Gordon J. Freeman

Specialty: PD-1 Signaling

Location: United States

Tier: TITAN

H-Index: 173

Years Active: 0

Hospital Affiliations

• Harvard University - Faculty

Key Publications

1. "Immune checkpoint TIM-3 regulates microglia and Alzheimer's disease." - Nature (2025)
2. "Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response." - Nat Med (2018)
3. "PD-1 and its ligands in tolerance and immunity." - Annu Rev Immunol (2008)
4. "Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis." - Cell (2021)
5. "ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy." - Nat Commun (2023)

Knowledge Graph Relationships

Gordon J. Freeman is a PD-1 Signaling specialist affiliated with Harvard University. Authored 5 scholarly articles.